Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations.

@article{Altshuler2018ClinicalOI,
  title={Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations.},
  author={Jerry Altshuler and David J Guervil and Charles D Ericsson and Audrey R. Wanger and Samuel L. Aitken and Luis L Ostrosky-Zeichner},
  journal={Journal of pharmacy practice},
  year={2018},
  volume={31 1},
  pages={34-39}
}
BACKGROUND The Clinical and Laboratory Standards Institute (CLSI) revised cefepime interpretive criteria, introducing the susceptible dose-dependent category for Enterobacteriaceae with a minimum inhibitory concentration (MIC) of 4 to 8 μg/mL in 2014. Limited clinical data support these new categories. This study compares outcomes of patients treated with… CONTINUE READING